Todd E. Simpson

Insider Reports History

Entity
Individual
Signature
/s/ Jennifer Prosba, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd E. Simpson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 8, 2023 Direct
Seagen Inc. Chief Financial Officer Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Chief Financial Officer Performance Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Chief Financial Officer Restricted Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Chief Financial Officer Stock Options (Right to Buy) 0 Dec 14, 2023 Direct

Insider Reports Filed by Todd E. Simpson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGEN Seagen Inc. Dec 14, 2023 27 -$21.4M 4 Dec 15, 2023 Chief Financial Officer
SGEN Seagen Inc. Sep 21, 2023 1 -$16.5K 4 Sep 22, 2023 Chief Financial Officer
SGEN Seagen Inc. Aug 31, 2023 1 -$439K 4 Sep 1, 2023 Chief Financial Officer
SGEN Seagen Inc. Aug 28, 2023 2 -$99.9K 4 Aug 30, 2023 Chief Financial Officer
SGEN Seagen Inc. Aug 15, 2023 4 -$680K 4 Aug 17, 2023 Chief Financial Officer
NLTX Neoleukin Therapeutics, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
SGEN Seagen Inc. Apr 10, 2023 6 -$8.76M 4 Apr 12, 2023 Chief Financial Officer
SGEN Seagen Inc. Apr 5, 2023 0 $0 4/A Apr 12, 2023 Chief Financial Officer
SGEN Seagen Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Chief Financial Officer
SGEN Seagen Inc. Mar 9, 2023 5 -$5.62M 4 Mar 10, 2023 Chief Financial Officer
SGEN Seagen Inc. Feb 27, 2023 1 -$3.65M 4 Feb 28, 2023 Chief Financial Officer
SGEN Seagen Inc. Feb 16, 2023 3 -$4.83M 4 Feb 21, 2023 Chief Financial Officer
SGEN Seagen Inc. Aug 31, 2022 2 -$646K 4 Sep 1, 2022 Chief Financial Officer
SGEN Seagen Inc. Aug 15, 2022 3 -$335K 4 Aug 17, 2022 Chief Financial Officer
NLTX Neoleukin Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
SGEN Seagen Inc. Apr 20, 2022 1 -$81.8K 4 Apr 22, 2022 Chief Financial Officer
SGEN Seagen Inc. Dec 20, 2021 1 -$51.7K 4 Dec 22, 2021 Chief Financial Officer
SGEN Seagen Inc. Nov 3, 2021 5 -$5.57M 4 Nov 5, 2021 Chief Financial Officer
SGEN Seagen Inc. Oct 29, 2021 3 -$4.66M 4 Nov 2, 2021 Chief Financial Officer
SGEN Seagen Inc. Sep 23, 2021 1 $33.4K 4 Sep 27, 2021 Chief Financial Officer
SGEN Seagen Inc. Aug 31, 2021 2 -$668K 4 Sep 2, 2021 Chief Financial Officer
SGEN Seagen Inc. Aug 16, 2021 4 -$82.4K 4 Aug 18, 2021 Chief Financial Officer
NLTX Neoleukin Therapeutics, Inc. May 11, 2021 1 $0 4 May 13, 2021 Director